The mammalian defense system can respond to a variety of threats, but this
capability is not just a simple alarm system for triggering antigen-present
ing cells and initiating cellular immunity. Instead, the body is an integra
ted system in which nearly every cell type can relay the alarm through the
production of chemokines, which recruit specific inflammatory cells to the
target tissues. This chemokine production is carefully regulated at several
levers so that the kinetics and character of local tissue inflammation is
tailored to the specific threat. First, the production of nuclear facror-ka
ppa B-regulated chemokines can be modulated in non-bone marrow-derived cell
s through transcriptional repression mediated by RelB. RelB is also implica
ted in the differentiation of lymphoid dendritic cells, suggesting that thi
s gene regulates the transition from acute inflammation to adaptive immunit
y Second, tissue parenchymal cells, in their capacity as sentinel cells, ar
e able to produce different patterns of chemokines in response to different
alarm stimuli. Third, cells from different tissues also show distinct pote
ntials for chemokine responses so that the non-specific damage from inflamm
ation might be avoided in some cases. Finally, the differentiation of T-cel
l effecters allows for further regulation of local inflammation as their cy
tokines can also affect chemokine production. This integration of innate an
d adaptive immunity allows for both rapid responses and dynamic regulation
of inflammation in vivo.